HEADER TRANSFERASE/TRANSFERASE INHIBITOR 13-NOV-15 5EQY TITLE CRYSTAL STRUCTURE OF CHOLINE KINASE ALPHA-1 BOUND BY 5-[(4-METHYL-1,4- TITLE 2 DIAZEPAN-1-YL)METHYL]-2-[4-[(4-METHYL-1,4-DIAZEPAN-1-YL) TITLE 3 METHYL]PHENYL]BENZENECARBONITRILE (COMPOUND 65) COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHOLINE KINASE ALPHA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 75-457; COMPND 5 SYNONYM: CK,CHETK-ALPHA,ETHANOLAMINE KINASE,EK; COMPND 6 EC: 2.7.1.32,2.7.1.82; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CHKA, CHK, CKI; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, INHIBITOR, DRUG TARGET, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.ZHOU,X.ZHU,D.C.DALGARNO REVDAT 4 27-SEP-23 5EQY 1 JRNL REMARK REVDAT 3 10-FEB-16 5EQY 1 JRNL REVDAT 2 13-JAN-16 5EQY 1 TITLE REVDAT 1 06-JAN-16 5EQY 0 JRNL AUTH S.G.ZECH,A.KOHLMANN,T.ZHOU,F.LI,R.M.SQUILLACE,L.E.PARILLON, JRNL AUTH 2 M.T.GREENFIELD,D.P.MILLER,J.QI,R.M.THOMAS,Y.WANG,Y.XU, JRNL AUTH 3 J.J.MIRET,W.C.SHAKESPEARE,X.ZHU,D.C.DALGARNO JRNL TITL NOVEL SMALL MOLECULE INHIBITORS OF CHOLINE KINASE IDENTIFIED JRNL TITL 2 BY FRAGMENT-BASED DRUG DISCOVERY. JRNL REF J.MED.CHEM. V. 59 671 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 26700752 JRNL DOI 10.1021/ACS.JMEDCHEM.5B01552 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.2 REMARK 3 NUMBER OF REFLECTIONS : 29542 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.223 REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.277 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 1466 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 29 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.53 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 858 REMARK 3 BIN R VALUE (WORKING SET) : 0.3943 REMARK 3 BIN FREE R VALUE : 0.5193 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 43 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5841 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 75 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.93 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.01000 REMARK 3 B22 (A**2) : -0.26800 REMARK 3 B33 (A**2) : 0.25800 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.510 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.618 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.130 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.312 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : AP30072_B_NEW.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5EQY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-NOV-15. REMARK 100 THE DEPOSITION ID IS D_1000215370. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-MAY-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU ULTRAX 18 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31277 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 5.900 REMARK 200 R MERGE (I) : 0.07900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 5.10 REMARK 200 R MERGE FOR SHELL (I) : 0.66800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: 3G15 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M SODIUM FORMATE, 8-12% PEG 3350, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.76150 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 65.23350 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 60.76600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 65.23350 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.76150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 60.76600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2350 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 33020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 57 REMARK 465 SER A 58 REMARK 465 SER A 59 REMARK 465 HIS A 60 REMARK 465 HIS A 61 REMARK 465 HIS A 62 REMARK 465 HIS A 63 REMARK 465 HIS A 64 REMARK 465 HIS A 65 REMARK 465 SER A 66 REMARK 465 SER A 67 REMARK 465 GLY A 68 REMARK 465 LEU A 69 REMARK 465 VAL A 70 REMARK 465 PRO A 71 REMARK 465 ARG A 72 REMARK 465 GLY A 73 REMARK 465 SER A 74 REMARK 465 PRO A 75 REMARK 465 GLN A 76 REMARK 465 PRO A 77 REMARK 465 PRO A 78 REMARK 465 ALA A 79 REMARK 465 ASP A 80 REMARK 465 GLU A 81 REMARK 465 ILE A 151 REMARK 465 LEU A 152 REMARK 465 GLN A 153 REMARK 465 MET A 154 REMARK 465 ARG A 155 REMARK 465 SER A 156 REMARK 465 CYS A 157 REMARK 465 ASN A 158 REMARK 465 LYS A 159 REMARK 465 GLU A 160 REMARK 465 GLY A 161 REMARK 465 SER A 162 REMARK 465 GLU A 163 REMARK 465 GLN A 164 REMARK 465 ALA A 165 REMARK 465 GLN A 166 REMARK 465 LYS A 167 REMARK 465 GLU A 168 REMARK 465 ASN A 169 REMARK 465 GLU A 170 REMARK 465 PHE A 171 REMARK 465 GLN A 172 REMARK 465 GLY A 173 REMARK 465 ALA A 174 REMARK 465 GLY B 57 REMARK 465 SER B 58 REMARK 465 SER B 59 REMARK 465 HIS B 60 REMARK 465 HIS B 61 REMARK 465 HIS B 62 REMARK 465 HIS B 63 REMARK 465 HIS B 64 REMARK 465 HIS B 65 REMARK 465 SER B 66 REMARK 465 SER B 67 REMARK 465 GLY B 68 REMARK 465 LEU B 69 REMARK 465 VAL B 70 REMARK 465 PRO B 71 REMARK 465 ARG B 72 REMARK 465 GLY B 73 REMARK 465 SER B 74 REMARK 465 PRO B 75 REMARK 465 GLN B 76 REMARK 465 PRO B 77 REMARK 465 PRO B 78 REMARK 465 ALA B 79 REMARK 465 ASP B 80 REMARK 465 GLU B 81 REMARK 465 ILE B 151 REMARK 465 LEU B 152 REMARK 465 GLN B 153 REMARK 465 MET B 154 REMARK 465 ARG B 155 REMARK 465 SER B 156 REMARK 465 CYS B 157 REMARK 465 ASN B 158 REMARK 465 LYS B 159 REMARK 465 GLU B 160 REMARK 465 GLY B 161 REMARK 465 SER B 162 REMARK 465 GLU B 163 REMARK 465 GLN B 164 REMARK 465 ALA B 165 REMARK 465 GLN B 166 REMARK 465 LYS B 167 REMARK 465 GLU B 168 REMARK 465 ASN B 169 REMARK 465 GLU B 170 REMARK 465 PHE B 171 REMARK 465 GLN B 172 REMARK 465 GLY B 173 REMARK 465 ALA B 174 REMARK 465 GLU B 175 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 88 -41.80 74.28 REMARK 500 SER A 121 -76.57 -101.81 REMARK 500 SER A 211 170.84 179.63 REMARK 500 PRO A 241 42.50 -71.07 REMARK 500 PRO A 246 61.65 -68.45 REMARK 500 THR A 266 -63.52 -102.27 REMARK 500 GLU A 267 126.20 -37.33 REMARK 500 ASN A 281 82.68 61.76 REMARK 500 ASN A 305 -11.64 82.00 REMARK 500 ASP A 306 47.60 -145.59 REMARK 500 GLU A 319 6.85 -69.68 REMARK 500 ASP A 330 77.09 59.15 REMARK 500 SER A 335 165.98 179.58 REMARK 500 ASN A 388 -77.74 -72.32 REMARK 500 ASN A 392 50.57 -118.25 REMARK 500 THR B 87 -29.59 -156.16 REMARK 500 MET B 177 -76.01 90.54 REMARK 500 PRO B 241 31.92 -71.87 REMARK 500 ASN B 281 61.61 67.62 REMARK 500 ASN B 305 -4.44 70.72 REMARK 500 ASP B 306 43.38 -144.48 REMARK 500 ARG B 318 17.34 -146.34 REMARK 500 GLU B 319 -16.39 -48.15 REMARK 500 ASP B 330 80.39 53.44 REMARK 500 PHE B 361 14.27 81.46 REMARK 500 PHE B 435 136.68 -174.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5RA A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5RA B 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5EQE RELATED DB: PDB REMARK 900 RELATED ID: 5EQP RELATED DB: PDB DBREF 5EQY A 75 457 UNP P35790 CHKA_HUMAN 75 457 DBREF 5EQY B 75 457 UNP P35790 CHKA_HUMAN 75 457 SEQADV 5EQY GLY A 57 UNP P35790 EXPRESSION TAG SEQADV 5EQY SER A 58 UNP P35790 EXPRESSION TAG SEQADV 5EQY SER A 59 UNP P35790 EXPRESSION TAG SEQADV 5EQY HIS A 60 UNP P35790 EXPRESSION TAG SEQADV 5EQY HIS A 61 UNP P35790 EXPRESSION TAG SEQADV 5EQY HIS A 62 UNP P35790 EXPRESSION TAG SEQADV 5EQY HIS A 63 UNP P35790 EXPRESSION TAG SEQADV 5EQY HIS A 64 UNP P35790 EXPRESSION TAG SEQADV 5EQY HIS A 65 UNP P35790 EXPRESSION TAG SEQADV 5EQY SER A 66 UNP P35790 EXPRESSION TAG SEQADV 5EQY SER A 67 UNP P35790 EXPRESSION TAG SEQADV 5EQY GLY A 68 UNP P35790 EXPRESSION TAG SEQADV 5EQY LEU A 69 UNP P35790 EXPRESSION TAG SEQADV 5EQY VAL A 70 UNP P35790 EXPRESSION TAG SEQADV 5EQY PRO A 71 UNP P35790 EXPRESSION TAG SEQADV 5EQY ARG A 72 UNP P35790 EXPRESSION TAG SEQADV 5EQY GLY A 73 UNP P35790 EXPRESSION TAG SEQADV 5EQY SER A 74 UNP P35790 EXPRESSION TAG SEQADV 5EQY GLY B 57 UNP P35790 EXPRESSION TAG SEQADV 5EQY SER B 58 UNP P35790 EXPRESSION TAG SEQADV 5EQY SER B 59 UNP P35790 EXPRESSION TAG SEQADV 5EQY HIS B 60 UNP P35790 EXPRESSION TAG SEQADV 5EQY HIS B 61 UNP P35790 EXPRESSION TAG SEQADV 5EQY HIS B 62 UNP P35790 EXPRESSION TAG SEQADV 5EQY HIS B 63 UNP P35790 EXPRESSION TAG SEQADV 5EQY HIS B 64 UNP P35790 EXPRESSION TAG SEQADV 5EQY HIS B 65 UNP P35790 EXPRESSION TAG SEQADV 5EQY SER B 66 UNP P35790 EXPRESSION TAG SEQADV 5EQY SER B 67 UNP P35790 EXPRESSION TAG SEQADV 5EQY GLY B 68 UNP P35790 EXPRESSION TAG SEQADV 5EQY LEU B 69 UNP P35790 EXPRESSION TAG SEQADV 5EQY VAL B 70 UNP P35790 EXPRESSION TAG SEQADV 5EQY PRO B 71 UNP P35790 EXPRESSION TAG SEQADV 5EQY ARG B 72 UNP P35790 EXPRESSION TAG SEQADV 5EQY GLY B 73 UNP P35790 EXPRESSION TAG SEQADV 5EQY SER B 74 UNP P35790 EXPRESSION TAG SEQRES 1 A 401 GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY LEU SEQRES 2 A 401 VAL PRO ARG GLY SER PRO GLN PRO PRO ALA ASP GLU GLN SEQRES 3 A 401 PRO GLU PRO ARG THR ARG ARG ARG ALA TYR LEU TRP CYS SEQRES 4 A 401 LYS GLU PHE LEU PRO GLY ALA TRP ARG GLY LEU ARG GLU SEQRES 5 A 401 ASP GLU PHE HIS ILE SER VAL ILE ARG GLY GLY LEU SER SEQRES 6 A 401 ASN MET LEU PHE GLN CYS SER LEU PRO ASP THR THR ALA SEQRES 7 A 401 THR LEU GLY ASP GLU PRO ARG LYS VAL LEU LEU ARG LEU SEQRES 8 A 401 TYR GLY ALA ILE LEU GLN MET ARG SER CYS ASN LYS GLU SEQRES 9 A 401 GLY SER GLU GLN ALA GLN LYS GLU ASN GLU PHE GLN GLY SEQRES 10 A 401 ALA GLU ALA MET VAL LEU GLU SER VAL MET PHE ALA ILE SEQRES 11 A 401 LEU ALA GLU ARG SER LEU GLY PRO LYS LEU TYR GLY ILE SEQRES 12 A 401 PHE PRO GLN GLY ARG LEU GLU GLN PHE ILE PRO SER ARG SEQRES 13 A 401 ARG LEU ASP THR GLU GLU LEU SER LEU PRO ASP ILE SER SEQRES 14 A 401 ALA GLU ILE ALA GLU LYS MET ALA THR PHE HIS GLY MET SEQRES 15 A 401 LYS MET PRO PHE ASN LYS GLU PRO LYS TRP LEU PHE GLY SEQRES 16 A 401 THR MET GLU LYS TYR LEU LYS GLU VAL LEU ARG ILE LYS SEQRES 17 A 401 PHE THR GLU GLU SER ARG ILE LYS LYS LEU HIS LYS LEU SEQRES 18 A 401 LEU SER TYR ASN LEU PRO LEU GLU LEU GLU ASN LEU ARG SEQRES 19 A 401 SER LEU LEU GLU SER THR PRO SER PRO VAL VAL PHE CYS SEQRES 20 A 401 HIS ASN ASP CYS GLN GLU GLY ASN ILE LEU LEU LEU GLU SEQRES 21 A 401 GLY ARG GLU ASN SER GLU LYS GLN LYS LEU MET LEU ILE SEQRES 22 A 401 ASP PHE GLU TYR SER SER TYR ASN TYR ARG GLY PHE ASP SEQRES 23 A 401 ILE GLY ASN HIS PHE CYS GLU TRP MET TYR ASP TYR SER SEQRES 24 A 401 TYR GLU LYS TYR PRO PHE PHE ARG ALA ASN ILE ARG LYS SEQRES 25 A 401 TYR PRO THR LYS LYS GLN GLN LEU HIS PHE ILE SER SER SEQRES 26 A 401 TYR LEU PRO ALA PHE GLN ASN ASP PHE GLU ASN LEU SER SEQRES 27 A 401 THR GLU GLU LYS SER ILE ILE LYS GLU GLU MET LEU LEU SEQRES 28 A 401 GLU VAL ASN ARG PHE ALA LEU ALA SER HIS PHE LEU TRP SEQRES 29 A 401 GLY LEU TRP SER ILE VAL GLN ALA LYS ILE SER SER ILE SEQRES 30 A 401 GLU PHE GLY TYR MET ASP TYR ALA GLN ALA ARG PHE ASP SEQRES 31 A 401 ALA TYR PHE HIS GLN LYS ARG LYS LEU GLY VAL SEQRES 1 B 401 GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY LEU SEQRES 2 B 401 VAL PRO ARG GLY SER PRO GLN PRO PRO ALA ASP GLU GLN SEQRES 3 B 401 PRO GLU PRO ARG THR ARG ARG ARG ALA TYR LEU TRP CYS SEQRES 4 B 401 LYS GLU PHE LEU PRO GLY ALA TRP ARG GLY LEU ARG GLU SEQRES 5 B 401 ASP GLU PHE HIS ILE SER VAL ILE ARG GLY GLY LEU SER SEQRES 6 B 401 ASN MET LEU PHE GLN CYS SER LEU PRO ASP THR THR ALA SEQRES 7 B 401 THR LEU GLY ASP GLU PRO ARG LYS VAL LEU LEU ARG LEU SEQRES 8 B 401 TYR GLY ALA ILE LEU GLN MET ARG SER CYS ASN LYS GLU SEQRES 9 B 401 GLY SER GLU GLN ALA GLN LYS GLU ASN GLU PHE GLN GLY SEQRES 10 B 401 ALA GLU ALA MET VAL LEU GLU SER VAL MET PHE ALA ILE SEQRES 11 B 401 LEU ALA GLU ARG SER LEU GLY PRO LYS LEU TYR GLY ILE SEQRES 12 B 401 PHE PRO GLN GLY ARG LEU GLU GLN PHE ILE PRO SER ARG SEQRES 13 B 401 ARG LEU ASP THR GLU GLU LEU SER LEU PRO ASP ILE SER SEQRES 14 B 401 ALA GLU ILE ALA GLU LYS MET ALA THR PHE HIS GLY MET SEQRES 15 B 401 LYS MET PRO PHE ASN LYS GLU PRO LYS TRP LEU PHE GLY SEQRES 16 B 401 THR MET GLU LYS TYR LEU LYS GLU VAL LEU ARG ILE LYS SEQRES 17 B 401 PHE THR GLU GLU SER ARG ILE LYS LYS LEU HIS LYS LEU SEQRES 18 B 401 LEU SER TYR ASN LEU PRO LEU GLU LEU GLU ASN LEU ARG SEQRES 19 B 401 SER LEU LEU GLU SER THR PRO SER PRO VAL VAL PHE CYS SEQRES 20 B 401 HIS ASN ASP CYS GLN GLU GLY ASN ILE LEU LEU LEU GLU SEQRES 21 B 401 GLY ARG GLU ASN SER GLU LYS GLN LYS LEU MET LEU ILE SEQRES 22 B 401 ASP PHE GLU TYR SER SER TYR ASN TYR ARG GLY PHE ASP SEQRES 23 B 401 ILE GLY ASN HIS PHE CYS GLU TRP MET TYR ASP TYR SER SEQRES 24 B 401 TYR GLU LYS TYR PRO PHE PHE ARG ALA ASN ILE ARG LYS SEQRES 25 B 401 TYR PRO THR LYS LYS GLN GLN LEU HIS PHE ILE SER SER SEQRES 26 B 401 TYR LEU PRO ALA PHE GLN ASN ASP PHE GLU ASN LEU SER SEQRES 27 B 401 THR GLU GLU LYS SER ILE ILE LYS GLU GLU MET LEU LEU SEQRES 28 B 401 GLU VAL ASN ARG PHE ALA LEU ALA SER HIS PHE LEU TRP SEQRES 29 B 401 GLY LEU TRP SER ILE VAL GLN ALA LYS ILE SER SER ILE SEQRES 30 B 401 GLU PHE GLY TYR MET ASP TYR ALA GLN ALA ARG PHE ASP SEQRES 31 B 401 ALA TYR PHE HIS GLN LYS ARG LYS LEU GLY VAL HET 5RA A 501 32 HET 5RA B 501 32 HETNAM 5RA 5-[(4-METHYL-1,4-DIAZEPAN-1-YL)METHYL]-2-[4-[(4-METHYL- HETNAM 2 5RA 1,4-DIAZEPAN-1-YL)METHYL]PHENYL]BENZENECARBONITRILE FORMUL 3 5RA 2(C27 H37 N5) FORMUL 5 HOH *75(H2 O) HELIX 1 AA1 PRO A 85 LEU A 99 1 15 HELIX 2 AA2 PRO A 100 ARG A 104 5 5 HELIX 3 AA3 ARG A 107 PHE A 111 5 5 HELIX 4 AA4 ALA A 176 ARG A 190 1 15 HELIX 5 AA5 THR A 216 SER A 220 5 5 HELIX 6 AA6 LEU A 221 GLY A 237 1 17 HELIX 7 AA7 LYS A 247 ARG A 262 1 16 HELIX 8 AA8 GLU A 267 SER A 279 1 13 HELIX 9 AA9 ASN A 281 SER A 295 1 15 HELIX 10 AB1 GLN A 308 GLY A 310 5 3 HELIX 11 AB2 ARG A 339 TRP A 350 1 12 HELIX 12 AB3 ILE A 366 TYR A 369 5 4 HELIX 13 AB4 THR A 371 GLN A 387 1 17 HELIX 14 AB5 ASN A 388 LEU A 393 5 6 HELIX 15 AB6 SER A 394 SER A 431 1 38 HELIX 16 AB7 GLY A 436 GLY A 456 1 21 HELIX 17 AB8 GLU B 84 LEU B 99 1 16 HELIX 18 AB9 PRO B 100 GLY B 105 5 6 HELIX 19 AC1 MET B 177 ARG B 190 1 14 HELIX 20 AC2 ASP B 215 SER B 220 5 6 HELIX 21 AC3 LEU B 221 MET B 238 1 18 HELIX 22 AC4 LYS B 247 LEU B 261 1 15 HELIX 23 AC5 GLU B 267 SER B 279 1 13 HELIX 24 AC6 ASN B 281 SER B 295 1 15 HELIX 25 AC7 GLN B 308 GLY B 310 5 3 HELIX 26 AC8 ARG B 339 GLU B 349 1 11 HELIX 27 AC9 ILE B 366 TYR B 369 5 4 HELIX 28 AD1 THR B 371 GLN B 387 1 17 HELIX 29 AD2 ASN B 388 LEU B 393 5 6 HELIX 30 AD3 SER B 394 SER B 431 1 38 HELIX 31 AD4 GLY B 436 GLY B 456 1 21 SHEET 1 AA1 5 HIS A 112 ARG A 117 0 SHEET 2 AA1 5 MET A 123 SER A 128 -1 O LEU A 124 N ILE A 116 SHEET 3 AA1 5 LYS A 142 LEU A 147 -1 O VAL A 143 N CYS A 127 SHEET 4 AA1 5 GLY A 203 GLN A 207 -1 O GLU A 206 N LEU A 144 SHEET 5 AA1 5 LEU A 196 PHE A 200 -1 N GLY A 198 O LEU A 205 SHEET 1 AA2 3 SER A 211 ARG A 213 0 SHEET 2 AA2 3 ILE A 312 LEU A 315 -1 O LEU A 314 N ARG A 212 SHEET 3 AA2 3 LEU A 326 LEU A 328 -1 O MET A 327 N LEU A 313 SHEET 1 AA3 2 VAL A 300 CYS A 303 0 SHEET 2 AA3 2 SER A 335 TYR A 338 -1 O ASN A 337 N VAL A 301 SHEET 1 AA4 2 TYR A 352 ASP A 353 0 SHEET 2 AA4 2 ARG A 363 ALA A 364 -1 O ARG A 363 N ASP A 353 SHEET 1 AA5 5 HIS B 112 ARG B 117 0 SHEET 2 AA5 5 SER B 121 SER B 128 -1 O GLN B 126 N SER B 114 SHEET 3 AA5 5 LYS B 142 GLY B 149 -1 O VAL B 143 N CYS B 127 SHEET 4 AA5 5 GLY B 203 GLN B 207 -1 O GLU B 206 N LEU B 144 SHEET 5 AA5 5 LEU B 196 PHE B 200 -1 N GLY B 198 O LEU B 205 SHEET 1 AA6 3 SER B 211 ARG B 213 0 SHEET 2 AA6 3 ILE B 312 LEU B 315 -1 O LEU B 314 N ARG B 212 SHEET 3 AA6 3 LEU B 326 LEU B 328 -1 O MET B 327 N LEU B 313 SHEET 1 AA7 2 VAL B 300 CYS B 303 0 SHEET 2 AA7 2 SER B 335 TYR B 338 -1 O SER B 335 N CYS B 303 SHEET 1 AA8 2 TYR B 352 ASP B 353 0 SHEET 2 AA8 2 ARG B 363 ALA B 364 -1 O ARG B 363 N ASP B 353 CISPEP 1 TYR A 359 PRO A 360 0 1.62 CISPEP 2 TYR B 359 PRO B 360 0 -1.15 SITE 1 AC1 10 ASP A 306 GLN A 308 TYR A 333 GLU A 349 SITE 2 AC1 10 TYR A 354 PHE A 361 TRP A 420 TRP A 423 SITE 3 AC1 10 GLU A 434 PHE A 435 SITE 1 AC2 9 ASP B 306 GLN B 308 TYR B 333 GLU B 349 SITE 2 AC2 9 TYR B 354 TRP B 420 ILE B 433 GLU B 434 SITE 3 AC2 9 PHE B 435 CRYST1 55.523 121.532 130.467 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018011 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008228 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007665 0.00000